Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Local, Multicenter, Non-interventional, Ambispective Study in Severe Hemophilia A Patients on Standard and PK-tailored Prophylaxis With Octocog Alfa (Advate®) in the Russian Federation

NCT04953000 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04953000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04953000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Local, Multicenter, Non-interventional, Ambispective Study in Severe Hemophilia A Patients on Standard and PK-tailored Prophylaxis With Octocog Alfa (Advate®) in the Russian Federation
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
August 19, 2021
Completion date
April 4, 2023
Enrollment
94 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a